Status:
COMPLETED
Genetics and Epigenetics of Graves' Orbitopathy
Lead Sponsor:
University of Pisa
Conditions:
Graves Ophthalmopathy
Eligibility:
All Genders
18-85 years
Brief Summary
Graves' orbitopathy (GO) is an autoimmune disease persisting when immunosuppression is achieved. Orbital fibroblasts from GO patients display peculiar phenotypes even if not exposed to autoimmunity, p...
Detailed Description
The investigators will establish primary cultures of orbital fibroblasts from orbital adipose tissue samples taken from six GO patients who underwent orbital decompressive surgery. Normal orbital tiss...
Eligibility Criteria
Inclusion
- Diagnosis of Graves' Orbitopathy
- Informed consent
Exclusion
- Lack of informed consent
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04488406
Start Date
January 1 2020
End Date
March 31 2020
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Cisanello-Endocrinology I and II
Pisa, Italy, 56124